Therapeutic comparison of flaxseed and black seed supplementation for treatment of type II diabetic patients: Therapeutic comparison of flaxseed and black seed supplementation

Asra  Abbas; Shahnai  Basharat; Momina  Shahid; Fatima  Raza; Nudrat  Tariq; Misbah  Arshad

doi:10.54393/pbmj.v5i3.304

Authors

Asra Abbas The University Institute of Diet and Nutritional Sciences, The University of Lahore
Shahnai Basharat The University Institute of Diet and Nutritional Sciences, The University of Lahore
Momina Shahid The University Institute of Diet and Nutritional Sciences, The University of Lahore
Fatima Raza The University Institute of Diet and Nutritional Sciences, The University of Lahore
Nudrat Tariq The University Institute of Diet and Nutritional Sciences, The University of Lahore
Misbah Arshad The University Institute of Diet and Nutritional Sciences, The University of Lahore

DOI:

https://doi.org/10.54393/pbmj.v5i3.304

Keywords:

Type II diabetes, flaxseed, blackseeds, hyperglycemia, anti-oxidant, anti-inflammatory

Abstract

Diabetes is one of the most prevailing global health issues. Genetic factors, obesity, environmental factors, poor dietary habits and sedentary life style are the main causes of its occurrence that leads to hyperglycemia and insulin resistance. In recent years therapeutic effects of dietary flaxseed and blackseed in management of diabetes has been studied. Both possess anti-oxidant, anti-hyperglycemic and anti-inflammatory properties. Secoisolariciresinol diglucoside (SDG) is a lignan present in flaxseed that lower the blood glucose level and fiber control insulin secretion and its mechanism of action. Thymoquinone (TQ) is a bioactive component present in flaxseed that control blood glucose level, insulin secretion and maintain glucose hemostasis. Both seeds are considered as highly acceptable with the great safety profile in management of type II diabetes. Therefore, this article highlights the therapeutic effects of flaxseed and blackseed supplementation in management of type II diabetes.

References

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C. Pathophysiology of type 2 diabetes mellitus. International journal of molecular sciences. 2020 Jan;21(17):1-34. doi: 10.3390/plants11050658.

Rehman A, Saeed A, Kanwal R, Ahmad S, Changazi SH. Therapeutic effect of sunflower seeds and flax seeds on diabetes. Cureus. 2021 Dec;13(8): 183-192. doi:10.7759/cureus.17256.

Deepthi B, Sowjanya K, Lidiya B, Bhargavi RS, Babu PS. A modern review of diabetes mellitus: an annihilatory metabolic disorder. J In Silico In Vitro Pharmacol. 2017 Mar;3(1).14-24.

Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan PF. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific reports. 2020 Sep 8;10(1):1-1. doi: 10.1038/s41598-020-71908-9.

International Diabetes Federation Diabetes Atlas, Pakistan press release [Internet]. Pakistan; Diabetesatlas.org; 2019 [cited 2021 Dec 13]. Available from: https://diabetesatlas.org/

Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophysiology, Natural History, and Prognosis. Diabetes 2017 Feb;66(2):241–255. doi:10.2337/db16-0806.

Kajla P, Sharma A, Sood DR. Flaxseed—a potential functional food source. Journal of food science and technology. 2015 Apr;52(4):1857-1871. doi: 10.1007/s13197-014-1293-y.

Oomah BD. Flaxseed as a functional food source. Journal of the Science of Food and Agriculture. 2001 Jul;81(9):889-894. doi:10.1002/jsfa.898.

Rubilar M, Gutiérrez C, Verdugo M, Shene C, Sineiro J. Flaxseed as a source of functional ingredients. Journal of soil science and plant nutrition. 2010 Jul;10(3):373-377. doi: 10.4067/S0718-95162010000100010.

Parikh M, Maddaford TG, Austria JA, Aliani M, Netticadan T, Pierce GN. Dietary flaxseed as a strategy for improving human health. Nutrients. 2019 May;11(5):1171. doi: 10.3390/nu11051171.

Parikh M, Netticadan T, Pierce GN. Flaxseed: its bioactive components and their cardiovascular benefits. American Journal of Physiology-Heart and Circulatory Physiology. 2018 Feb 1;314(2):H146-159. doi: 10.1152/ajpheart.00400.2017.

Ganorkar PM, Jain RK. Effect of flaxseed incorporation on physical, sensorial, textural and chemical attributes of cookies. International Food Research Journal. 2014 Aug 1;21(4).1515-1521.

Prasad K, Dhar A. Flaxseed and diabetes. Current Pharmaceutical Design. 2016 Jan 1;22(2):141-144.

Hamdan A, Haji Idrus R, Mokhtar MH. Effects of Nigella sativa on type-2 diabetes mellitus: a systematic review. International journal of environmental research and public health. 2019 Jan;16(24):4911. doi: 10.3390/ijerph16244911.

Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Zeitschrift für Naturforschung C. 2003 Oct 1;58(9-10):629-631. /doi: 10.1515/znc-2003-9-1004.

Tembhurne SV, Feroz S, More BH, Sakarkar DM. A review on therapeutic potential of Nigella sativa (kalonji) seeds. Journal of Medicinal Plants Research. 2014 Jan 17;8(3):167-177.

Khoddami A, Ghazali HM, Yassoralipour A, Ramakrishnan Y, Ganjloo A. Physicochemical characteristics of nigella seed (Nigella sativa L.) oil as affected by different extraction methods. Journal of the American Oil Chemists' Society. 2011 Apr;88(4):533-540. doi:10.1007/s11746-010-1687-6.

Maideen NM. Antidiabetic Activity of Nigella Sativa (Black Seeds) and Its Active Constituent (Thymoquinone): A Review of Human and Experimental Animal Studies. Chonnam Medical Journal. 2021 Sep;57(3):169.

Mathur ML, Gaur J, Sharma R, Haldiya KR. Antidiabetic properties of a spice plant Nigella sativa. Journal of Endocrinology and Metabolism. 2011 Feb;1(1):1-8. doi: https://doi.org/10.4021/jem12e.

Butt MS, Sultan MT. Nigella sativa: reduces the risk of various maladies. Critical reviews in food science and nutrition. 2010 Jul 30;50(7):654-665. doi: 10.1080/10408390902768797.

Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE. Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutrition Research. 2013 May;33(5):367–375. doi: 10.1016/j.nutres.2013.02.012.

Pan A, Sun J, Chen Y, Ye X, Li H, Yu Z, Wang Y, Gu W, Zhang X, Chen X, Demark-Wahnefried W. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One. 2007 Nov ;2(11):1148-1157. doi: 10.1371/journal.pone.0001148.

Tharwat S, Shaheen D, El-Megeid AA, Salam R, Rashed L, El-Hamid S, Abdel-Shafy S, Shaheen D. Effectiveness of Adding Flaxseed to Type 2 Diabetic Patient’s Regimen. Endocrinology & Metabolic Syndrome. 2017 Jan;6(3):267-271. doi: 10.4172/2161-1017.1000267.

Zhu L, Sha L, Li K, Wang Z, Wang T, Li Y, Liu P, Dong X, Dong Y, Zhang X, Wang H. Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats. Lipids in health and disease. 2020 Feb;19(1):1-6. doi: 10.1186/s12944-019-1167-4.

Elshal MF, Kumosani TA, Abulnaja KO. Influence of defatted flaxseed diet on insulin sensitivity, vascular permeability and lipid profile in a rat model of type 2 diabetes mellitus. Journal of Medicinal Plants Research. 2012 Mar;6(11):2188-2193.

Haliga R, Mocanu V, Oboroceanu T, Stitt PA, Luca VC. The effects of dietary flaxseed supplementation on lipid metabolism in streptozotocin-induced diabetic hamsters. Revista Medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2007 Apr;111(2):472–476.

Wang Y, Fofana B, Roy M, Ghose K, Yao XH, Nixon MS, Nair S, Nyomba GB. Flaxseed lignan secoisolariciresinol diglucoside improves insulin sensitivity through upregulation of GLUT4 expression in diet-induced obese mice. Journal of Functional Foods. 2015 Oct ;18:1-9. doi: 10.1016/j.jff.2015.06.053.

Velasquez MT, Bhathena SA, Ranich T, Schwartz AM, Kardon DE, Ali AL, Haudenschild CC, Hansen CT. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney international. 2003 Dec ;64(6):2100-2107. doi: 10.1046/j.1523-1755.2003.00329.x.

Bilal A, Masud T, Uppal AM, Naveed AK. Effects of Nigella sativa oil on some blood parameters in type 2 diabetes mellitus patients. Asian Journal of Chemistry. 2009 Aug 10;21(7):5373-5381.

Hosseini MS, Mirkarimi SA, Amini M, Mohtashami R, Kianbakht S, FALLAH HH. Effects of Nigella sativa L. seed oil in type II diabetic Patients: a randomized, double-blind, placebo-controlled clinical trial Journal of Medicinal Plants .2013 Sep;12(47):93-99.

Kaatabi H, Bamosa AO, Badar A, Al-Elq A, Abou-Hozaifa B, Lebda F, Al-Khadra A, Al-Almaie S. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo-controlled participant blinded clinical trial. PloS one. 2015 Feb 23;10(2):321-405. doi: 10.1371/journal.pone.0113486.

Fararh KM, Atoji Y, Shimizu Y, Shiina T, Nikami H, Takewaki T. Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocin-induced diabetic hamsters. Research in veterinary science. 2004 Oct 1;77(2):123-129. doi: 10.1016/j.rvsc.2004.03.002.

Kanter M, Coskun O, Korkmaz A, Oter S. Effects of Nigella sativa on oxidative stress and β‐cell damage in streptozotocin‐induced diabetic rats. The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology: An Official Publication of the American Association of Anatomists. 2004 Jul;279(1):685-691. doi: 10.1002/ar.a.20056.

Kaleem M, Kirmani D, Asif M, Ahmed Q, Bano B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian Journal of Experimental Biology: 2006 Sep; 44 (09) 745-748.

Abdelmeguid NE, Fakhoury R, Kamal SM, Al Wafai RJ. Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β‐cells of streptozotocin‐induced diabetic rats. Journal of diabetes. 2010 Dec;2(4):256-266. doi: 10.1111/j.1753-0407.2010.00091.x.

Moustafa HA, El Wakeel LM, Halawa MR, Sabri NA, El-Bahy AZ, Singab AN. Effect of Nigella Sativa oil versus metformin on glycemic control and biochemical parameters of newly diagnosed type 2 diabetes mellitus patients. Endocrine. 2019 Aug;65(2):286-294. doi: 10.1007/s12020-019-01963-4.

Hasaniani N, Rahimlou M, Ahmadi AR, Khalifani AM, Alizadeh M. The effect of flaxseed enriched yogurt on the glycemic status and cardiovascular risk factors in patients with type 2 diabetes mellitus: randomized, open-labeled, controlled study. Clinical nutrition research. 2019 Oct ;8(4):284-295. doi: 10.7762/cnr.2019.8.4.284.

Thakur G, Mitra A, Pal K, Rousseau D. Effect of flaxseed gum on reduction of blood glucose and cholesterol in type 2 diabetic patients. International journal of food sciences and nutrition. 2009 Sep:60(S6)126-136. doi: 10.1080/09637480903022735.

Mani UV, Mani I, Biswas M, Kumar SN. An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus. Journal of dietary supplements. 2011 Sep;8(3):257-265. doi: 10.1080/09637480903022735.

Bilal A, Masud T, Uppal AM, Naveed AK. Effects of Nigella sativa oil on some blood parameters in type 2 diabetes mellitus patients. Asian Journal of Chemistry. 2009 Aug 10;21(7):5373-5381.

Hosseini MS, Mirkarimi SA, Amini M, Mohtashami R, Kianbakht S, FALLAH HH. Effects of Nigella sativa L. seed oil in type II diabetic Patients: a randomized, double-blind, placebo-controlled clinical trial Journal of Medicinal Plants .2013 Sep;12(47):93-99.

Kaatabi H, Bamosa AO, Badar A, Al-Elq A, Abou-Hozaifa B, Lebda F, Al-Khadra A, Al-Almaie S. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo-controlled participant blinded clinical trial. PloS one. 2015 Feb 23;10(2):321-405. doi: 10.1371/journal.pone.0113486.